Table 3.
Agent | SPT dilutions (mg/mL) | IDT dilutions (mg/mL)a |
---|---|---|
Carboplatin | 10 | 0.1 |
1 | ||
5b | ||
Oxaliplatin | 5 | 0.05 |
0.5 | ||
5 | ||
Cisplatin | 1 | 0.01 |
0.1 | ||
1 |
Variations exist: the European Academy of Allergy and Clinical Immunology (EAACI) recommends concentrations of 10 and 1 mg/mL for carboplatin SPT and IDT and 1 and 0.1 mg/mL for oxaliplatin and cisplatin SPT and IDT [73]
SPT skin prick test, IDT intradermal test
aFor intradermal tests, 0.02–0.03 mL is used
bReported concentrations for the last IDT step include 3, 5, and 10 mg/mL; 10 mg/mL has been reported to cause local skin necrosis and is therefore not recommended